Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Plasma cell 1Other solid neoplasm 1Other 1NET 1Endocrine 1Dermatologic 1Breast 1

Conditions

Acute Graft Versus Host Disease 1

Interventions

Tirzepatide 5Educational Status 4Methods 3Interviews as Topic 3Early Intervention, Educational 3semaglutide 2naldemedine 2Standard of Care 2Specimen Handling 2Radiotherapy 2Paclitaxel 2Observation 2Mouthwashes 2Metformin 2Exercise 2Counseling 2Cisplatin 2Carboplatin 2trametinib 1tempol 1sotorasib 1selpercatinib 1polyethylene glycol 3350 1pembrolizumab 1osimertinib 1naloxegol 1mirabegron 1maltodextrin 1ma zi ren wan 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leflunomide × Other × Clear all
NCT05443425 2025-07-04

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

City of Hope Medical Center

Phase 1 Recruiting
18 enrolled
Other

Acute Graft Versus Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡